Skip to main content
. 2011 Jun 28;437(Pt 2):185–197. doi: 10.1042/BJ20110327

Figure 2. RvE1 has potent and stereoselective action on human platelets.

Figure 2

(A) RvE1 (grey) and its stable isomer 19-para-fluorophenoxy-RvE1 (black) both reduced ADP-stimulated platelet aggregation. The biologically inactive isomer of RvE1, Δ6,14-trans isomer (red) did not block ADP-stimulated platelet aggregation. (B) Representative real-time aggregation tracings for Δ6,14-trans isomer (left-hand panel) and 19-para-fluorophenoxy-RvE1 (right-hand panel).